Quantitative Models of Phage-Antibiotic Combination Therapy

Area of Science:

• Microbiology
• Computational Biology
• Pharmacology

Background:

• Multidrug-resistant (MDR) bacteria pose a global health threat.
• Bacteriophage therapy offers an alternative for MDR infections but faces challenges from bacterial resistance.
• Combination therapy with phages and antibiotics is being explored to overcome resistance.

Purpose of the Study:

• To develop and analyze a nonlinear population dynamics model for phage-antibiotic combination therapy in vivo.
• To investigate the interactions between bacteria, phage, antibiotics, and the immune response.
• To assess the robustness of combination therapy against varying pathogen resistance profiles.

Main Methods:

• Developed a nonlinear population dynamics model simulating bacteria, phage, and antibiotic interactions.
• Modeled two strains of Pseudomonas aeruginosa with differing resistance profiles.
• Incorporated innate immune responses into the simulation for in vivo application.

Main Results:

• Combination therapy demonstrated superior efficacy compared to monotherapy with either phage or antibiotics.
• Innate immune responses significantly enhanced the effectiveness of combination therapy.
• Successful treatment outcomes were achievable even with sub-inhibitory antibiotic concentrations.

Conclusions:

• Phage-antibiotic combination therapy is a promising strategy for combating MDR bacterial infections.
• The innate immune system plays a crucial role in modulating therapeutic success.
• The model provides insights into optimizing combination therapy protocols for clinical application.